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Abstract 
The transcription factor hepatocyte nuclear factor 1β (HNF1β) is ubiquitously overexpressed 
in ovarian clear cell carcinoma (CCC) and is a potential therapeutic target.  To explore 
potential approaches that block HNF1β transcription we have identified and characterised 
extensively the nuclear localisation signal (NLS) for HNF1β and its interactions with the 
nuclear protein import receptor, Importin-α.  Pull-down assays demonstrated that the DNA 
binding domain of HNF1β interacted with a spectrum of Importin-α isoforms and deletion 
constructs tagged with eGFP confirmed that the HNF1β 
229
KKMRRNR
235
 sequence was 
essential for nuclear localisation.  We further characterised the interaction between the NLS 
and Importin-α using complementary biophysical techniques and have determined the 2.4 Å 
resolution crystal structure of the HNF1β NLS peptide bound to Importin-α. The functional, 
biochemical, and structural characterisation of the nuclear localisation signal present on 
HNF1β and its interaction with the nuclear import protein Importin-α provide the basis for the 
development of compounds targeting transcription factor HNF1β via its nuclear import 
pathway. 
 
Keywords: Importin-α, nuclear import pathway, nuclear localisation signal sequence (NLS), 
Hepatocyte nuclear factor-1β (HNF1β), site-directed mutagenesis, X-ray crystallography, 
isothermal titration calorimetry. 
 
Abbreviations:  CCC - Ovarian clear cell carcinoma; HNF1 - hepatocyte nuclear factor 1;  
HNF1
DBD
 - HNF1 DNA binding domain; NLS - nuclear localization signal; IBB - Importin--
binding domain; mImportin-α - mouse Importin-α; xImportin-α - Xenopus Importin-α; GST - 
glutathione S-transferase. 
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Introduction 
Ovarian clear cell carcinoma (CCC) accounts for 5-10% of ovarian cancer cases (Anglesio et 
al., 2011; Kato et al., 2008).  Prognosis for patients with advanced stage or for relapsed 
disease is poor because of intrinsic resistance to platinum based chemotherapy and the lack 
of targeted therapies available (Tan et al., 2013; Tan and Kaye, 2007), although Bitler et al. 
(2015) have recently discovered a way of targeting cancers with ARID1A mutations by 
targeting EZH2 methyltransferase activity.  Common mutations in CCC include loss of 
function mutations in the chromatin remodeling gene ARID1A in 46–57% of cases (Jones et 
al., 2010; Wiegand et al., 2010), activating mutations in PIK3CA (Kuo et al., 2009) in 33–46% 
of cases, and loss of PTEN in 20% of cases (Anglesio et al., 2011; Landen et al., 2008; Tan 
and Kaye, 2007).  Overexpression of the HNF1β transcription factor is the most important 
clinical immunohistochemical marker for the disease because it is ubiquitously overexpressed 
in CCC, both at the mRNA and protein level (Hirotaka Kajihara, 2010; Kato et al., 2006; 
Tsuchiya et al., 2003; Yamaguchi et al., 2010).  In CCC the HNF1B gene is upregulated by 
hypomethylation of its CpG island whereas, in high grade serous ovarian cancer, HNF1β 
expression is silenced via hypermethylation (Kato et al., 2008; Shen et al., 2013a), 
suggesting that HNF1β has a loss of function (tumour suppressor) role in high grade serous 
ovarian cancer but a gain of function (oncogenic) role in CCC (Gounaris et al., 2011; Shen et 
al., 2013b).  This hypothesis is supported by the observation that nearly half of the 
overexpressed genes identified in CCC are downstream targets of HNF1β (Kobayashi et al., 
2009; Yoshida et al., 2009).  Evidence that targeting HNF1β might have utility was provided 
by Liu et al. (Liu et al., 2009) who showed that downregulation of HNF1β increased cisplatin- 
and paclitaxel-mediated cytotoxicity. 
 
 Transcription factor HNF1β (also known as vHNF1, vAPF, LF-B3 and Tcf2) is 
expressed in the liver, digestive tract, pancreas and the kidneys, where it plays a crucial role 
in early differentiation (Lu et al., 2007).  Sequence-specific DNA binding is mediated by a 
bipartite motif that consists of a POU homeodomain (POUH) and a POU specific domain 
(POUS) (Rosenfeld, 1991; Ryan and Rosenfeld, 1997).  HNF1β has 70% sequence homology 
to HNF1α and both proteins are atypical members of the POU transcription factor family and 
bind DNA as both homo- and heterodimers (Bach et al., 1991; Rey-Campos et al., 1991).  
Human HNF1β is constructed from three domains: the dimerization domain, which is further 
stabilised by the dimerization cofactor of HNF1 (DcoH), the transactivation domain, which is 
involved in binding transcriptional co-activators [15], and the POU DNA binding domain 
(HNF1
DBD
). 
 
 Transcription factors together with histones, DNA polymerase, RNA polymerase and 
many other proteins, have specific amino acid sequences, termed nuclear localisation signals 
(NLSs), that are recognised by members of the karyopherin family that facilitate their nuclear 
import (reviewed by Lange et al., 2007).  Many NLS sequences are recognised in the 
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4 
cytoplasm by a heterodimeric transport carrier complex composed of Importin-β (also known 
as Karyopherin-β1) and Importin-α (reviewed by Stewart, 2007).  Nuclear pore complexes 
(NPCs) are the channels through which macromolecules, such as proteins and RNA, are 
transported between the cytoplasm and nucleus (reviewed by Stewart, 2007).  Small 
molecules and proteins (< 40 kDa) can pass through NPCs by passive diffusion, but larger 
proteins require carriers to overcome the NPC physical barrier.  The autoinhibitory Importin-
β binding (IBB) domain of Importin-α (Kobe, 1999) binds to Importin-β in the cytoplasm, 
enabling classical NLSs (cNLS) to bind to Importin-α either via a major site, a minor site, or 
both (Fontes et al., 2000; Lange et al., 2007). There are two types of cNLS that are 
recognised by Importin-α that consist of a either a single cluster (monopartite) or two clusters 
(bipartite) of positively charged residues, primarily lysines or arginines, that assume an 
ordered state once bound by Importin-α (reviewed by Lange et al. 2007; Marfori et al., 2011).  
Monopartite cNLSs are exemplified by the simian virus 40 large T-antigen (SV40) NLS 
126
PKKKRRV
132
 (Lange et al., 2007).  The cargo:carrier heterotrimer is then translocated into 
the nucleus in an energy dependent manner powered by RanGTPase (reviewed by Stewart, 
2007).  In the nucleus, RanGTP then binds Importin-β leading ultimately to the release of the 
cargo. 
 
 To function, HNF1β needs to be translocated to the cell nucleus and so we have 
investigated and characterized the putative NLS that has been proposed to lie between the 
two POU domains of HNF1β.  This putative NLS was identified in domain swapping 
experiments and studies of nephrogenesis, in which truncated GFP-HNF1β fusion constructs 
retaining the POUH domain showed exclusive nuclear localisation in transfected HeLa cells 
(Bohn et al., 2003; Wu et al., 2004).  However, the precise location of the HNF1β NLS has not 
been defined.  Because of the potential importance of HNF1β as a target in diseases such as 
CCC, we have identified and characterized extensively its NLS and its interactions with 
Importin-α.  We demonstrate that the sequence 
229
KKMRRNR
235
 in HNF1β
DBD
 is responsible 
for the nuclear import of the protein.  Several eGFP-constructs of HNF1β were generated and 
Importin-α binding of the HNF1β
DBD
 was assessed by both pull-down experiments and ITC.  
We also determined the crystal structure of the HNF1β NLS peptide bound to Importin-α.  The 
identification and structural characterisation of the HNF1β NLS and its interaction with the 
nuclear import protein Importin-α provides a basis for the development of inhibitors targeting 
the nuclear import of transcription factor HNF1β along the lines suggested by Stelma et al. 
(2016). 
 
Materials and Methods 
 
Mammalian cell culture 
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5 
HEK293T cells were cultivated in Dulbecco’s Modified Eagle medium (DMEM) (1X) 
supplemented with 5% foetal bovine serum (FBS) (Invitrogen) and 0.5% 
penicillin/streptomycin (P/S).  CCC cell lines PEO1, JHOC5, JHOC7, JHOC9, OVISE and 
SKOV3 cells were grown in RPMI 1640 medium (1X) supplemented with 10% FBS and 
1% P/S.  Normal Ovarian Surface Epithelial (IOSE) cells were cultivated in NOSE-CM: MCDB 
105/medium 199 (1:1 ratio, Sigma Aldrich), 15% FBS, 10 ng/ml EGF (Invitrogen), 0.5 μg/ml 
hydrocortisone (Sigma Aldrich), 5 μg/ml insulin (Sigma Aldrich), 34 μg protein/ml BPE 
(Invitrogen).  All cell lines were maintained at 37°C in 5% CO2 and were mycoplasma tested 
on a regular basis (Biorepository Core, CRUK CI, Cambridge).  Cell counts were conducted 
using a Vi-CELL Cell Viability Analyzer. 
 
Protein extraction from mammalian cells 
Cell pellets were washed with phosphate buffered saline (PBS) and 200 μl protein lysis buffer 
(50 mM Tris pH 8.0, 150 mM NaCl, 5 mM EDTA, 0.5% Igepal, to which 2 tablets/100ml of 
protease inhibitor cocktail tablet (Roche)) was added.  The mixtures were incubated on ice for 
30 min, lysed by syringing four times using a 26 G needle, and centrifuged at 14,800 × g for 
10 min at 4°C.  Protein concentrations were measured using the DirectDetect IR 
spectrometer (Merck Millipore) according to the manufacturer’s instructions. 
 
Western blotting 
Denatured protein extracts were separated using NuPAGE Novex 4-20% Tris-Glycine gels 
and transferred to a Millipore Immobilon FL PVDF membrane (Invitrogen).  Primary 
antibodies were used as follows: goat anti-HNF1β (sc-7411, polyclonal, Santa Cruz 
Biotechnology, 1:1,000) and rabbit anti-GAPDH (G9545, 14C10, 1:5,000, Cell Signalling 
Technology).  An Odyssey Infrared Imaging System (Li-Cor) and associated secondary 
antibodies: donkey anti-goat (800) (1:15,000) and donkey anti-rabbit (800) (1:5,000) were 
used to detect material. The expression levels observed with different cells were evaluated 
using GraphPad Prism version 6.0 for Mac, GraphPad Software, La Jolla California USA, 
www.graphpad.com.  Analysis of variance rejected the null hypothesis that the expression 
levels were equal (P < 0.002) and Šídák's multiple comparison modification of Student's t-test 
was used to evaluate the significance of the levels seen with different cells relative to that 
seen with the control HGSOC cell line. 
 
Confocal microscopy: eGFP imaging and immunofluorescence assay 
For immunofluorescence (IF), cells were fixed with 4% paraformaldehyde in PBS for 10 min 
at room temperature, rinsed in Tris buffered saline (TBS) for 2 × 5 min and permealized in 
TBS-0.5% Triton X-100 for 10 min.  Fixed cells were then rinsed in TBS-0.1% Triton X-100 for 
3 × 3 min and blocked in 10% goat serum in TBS for 30 min.  HNF1β was stained with anti-
HNF1β (SAB1406512, mouse polyclonal, 1:300, Sigma Aldrich) overnight at 4°C. Cells were 
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6 
washed with TBS-0.1% Triton X-100 (Fisher Scientific) for 3 × 5 min and the secondary 
antibody (AlexaFluor 568, goat anti-mouse IgG (H+L) 1:1,000, Invitrogen) was added and 
incubated for 60 min diluted in antibody dilution solution consisting of TBS - 0.1% Triton X-
100, 2% Bovine Serum Albumin (BSA) (Cell Signaling Technology) and 0.1% sodium azide.  
All experiments included an unstained control, a “secondary only” control, and a negative 
control using the PEO1 cell line.  Cells transduced with eGFP-HNF1β, the HNF1β 
229
KKMRRNR
235
 deletion mutant, or the control eGFP constructs, were fixed with 4% 
paraformaldehyde in PBS for 10 min at room temperature, then rinsed in TBS for 2 × 5 min.  
Nuclei were stained using DAPI (1 μg/ml in TBS) for 10 min.  Cells were washed in TBS-0.1% 
Triton X-100, rinsed in TBS and stored in TBS-0.1% Triton X-100.  For microscopy imaging, 
cover slips were drained, mounted and sealed using Prolong Gold (Invitrogen) and glass 
slides (Thermo Specific).  Slides were left to dry overnight at room temperature in the 
absence of light and were then stored at 4◦C.  Cells were imaged using a Leica tandem 
confocal microscope. 
 
Site directed mutagenesis to generate HNF1β NLS deletion construct 
Lv103 (EX-F0366-Lv103, Genecopoeia) is a lentiviral transfer vector containing an eGFP-
HNF1β fusion coding sequence.  Lv105 (EX-EGFP-Lv105, Genecopoeia) only contains the 
eGFP coding sequence.  The plasmids were confirmed by sequencing (GATC, Konstanz, 
Germany) before and after mutagenesis (Lv103 Fw: 5’-CCGACAACCACTACCTGA-3’; Rv: 5’-
ATTGTGGATGAATACTGCC-3’ and Lv105 Fw: 5’-ATCCACGCTGTTTTGACC-3’; Rv: 5’-
AATACTGCCATTTGTCTCG-3’). 
 
 Mutagenesis experiments were conducted using the Q5 site directed mutagenesis kit 
(NEB).  The 
229
KKMRRNR
235
 deletion construct was generated using mutagenesis primers 
(Fw: 5’-TTCAAATGGGGGCCGC-3’; Rv: 5’-GTTGGTGGGCTCAGAGCAG-3’).  Plasmids 
were then transformed in E. coli (One Shot® Stbl3™, Invitrogen) and streaked on Amp-
containing agar plates.  Single colonies were picked and tested for plasmid containing 
colonies by PCR.  Plasmids were extracted by Plasmid Mini Prep (Qiagen) and quantified 
(Qubit). 
 
Lentivirus production and transduction 
The general protocol devised by Cribbs et al. (2013) was used for lentivirus production. The 
transfer vectors Lv103, Lv105, the 
229
KKMRRNR
235
 deletion mutant, and plasmids pRVS-Rev, 
pVSV-G, and p-MDLg-pRRE were verified by restriction digest.  For each transfection 
sample, 16 μg transfer vector, 10.4 μg pMDL/pRRE, 4 μg pRSV-Rev and 5.6 μg pVSV-G 
were used.  After 24 h, expression of GFP protein was observed in the GFP control virus 
HEK293T sample.  Virus containing supernatant was harvested posttransfection according to 
the protocol by Kutner et al. (2009). The number of transducing units (TU) was determined by 
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7 
flow cytometry analysis with GFP as the reporter protein.  For titration, 1 × 10
5
 cells per well 
were seeded in a 12-well plate and 0.5 ml DMEM with 5% FBS added.  Virus of respective 
concentration was pipetted over the HEK293T cells.  Duplicate virus dilutions of 1:500, 
1:1000, 1:2000, 1:5000 were added.  An untreated control was included.  The medium was 
changed 24 h posttransfection.  72 h posttransfection cells were harvested by trypsinization.  
Cells were collected by centrifugation at 500 × g for 5 min at room temperature.  The 
supernatant was discarded and cell pellets were resuspended in PBS.  A green fluorescent 
protein propidium iodide (GFP PI) based assay for flow cytometric measurement of 
transfection efficiency and cell viability was performed (LSR-II machine).  The titre was 
calculated from dilutions that gave 1–40% GFP-positivity and averaged subsequently using 
the following formula: 
 
       
  
  
  
                                                                      
                  
 
 
where, frequency of GFP-positive cells is the percentage of cells that are positive for GFP 
divided by 100 (acceptable range: 0.01–0.40), dilution factor is the dilution of the virus stock 
used and volume of inoculum is the total volume transduced.  The titre was calculated to be 
         
  
  
. 
 
 For transduction of the PEO1 cell line,         cells per well were seeded in a 12-
well plate to which 0.5 ml of the respective medium was added.  Virus was added so that the 
desired multiplicity of infection (MOI) was obtained.  Polybrene 0.5-10 μg/ml was added to 
increase transduction efficiency.  Transduction efficiencies were determined by flow 
cytometry analysis using an LSR-II machine.  For selection of transduced PEO1 lines, a 
puromycin kill curve was constructed (data not shown) to determine the optimum 
concentration of puromycin required to kill all untransduced cells while minimising toxicity 
effects in transduced cells.  A puromycin concentration of 0.1 μg/ml was determined which 
was used in all experiments. 
 
Quick change mutagenesis to generate GST-tagged HNF1β
DBD
 and mImportin α1 
mutants 
The cloning of the DNA binding domain of HNF1β into the pGEX-TEV plasmid was conducted 
as described by Lu et al. (2006).  The plasmid was confirmed by sequencing by Source 
Bioscience (Cambridge, UK) using PGEX5 and PGEX3 primers (Source Bioscience). 
 
Protein expression in bacterial cells and purification 
All proteins were expressed in E. coli BL21 (DE3) CodonPlus-RIL cells using IPTG induction 
over 18 h at 18°C. The cells were harvested by centrifugation and resuspended in 50 mM 
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8 
Tris/HCl pH 8.0, 500 mM NaCl, 5 mM DTT for GST-tagged constructs or 50 mM Tris/HCl pH 
8.0, 500 mM NaCl, 20 mM Imidazole pH 8.0 for His6-tagged proteins.  The E. coli were lysed 
by two passes through an Emulsiflex C3 system (AVESTIN) running at a pressure of 
15,000 psi and the lysates clarified by centrifugation at 48,000 × g.  Either Ni-NTA agarose 
resin (QIAGEN) or glutathione Sepharose 4B resin (GE Healthcare) was added to the 
clarified lysate containing His6-tagged proteins or GST-tagged proteins.  The resin was 
pooled and packed into a gravity filtration column and washed extensively with their 
respective lysis buffers.  1 mg of TEV protease (purified in-house) was added to the washed 
resin and incubated for 18 h at 4°C.  The tag-free protein of interest was then collected from 
the flow-through and subjected to the next purification step.  HNF1β
DBD
 was purified further by 
heparin affinity chromatography using a HiTrap Heparin HP column (GE Healthcare Life 
Sciences).  HNF1β
DBD
 was eluted from the column using a 0.1 - 1 M NaCl gradient.  All 
proteins were purified to homogeneity by size exclusion chromatography using a HiLoad™ 
26/60 Superdex™ 75 prep grade column (GE Healthcare) pre-equilibrated in 20 mM HEPES 
buffer pH 8.0, 200 mM NaCl.  Fractions containing pure and homogenous proteins identified 
by SDS-PAGE analysis were pooled and concentrated using an Amicon Ultra 15 
centrifugation filtration unit.  Protein concentrations were measured using a Nanodrop 
(Thermo) microspectrophotometer and small aliquots of the protein were flash frozen in liquid 
nitrogen and stored at -80°C until required. 
 
GST pull-downs 
After bacterial cell lysis, cell pellets expressing the two proteins of interest were mixed and 
pull-down experiments were conducted as described above for glutathione affinity 
chromatography and were visualised by SDS-page analysis. 
 
Isothermal calorimetry 
The Kd of mImportin-α1 with the HNF1β NLS peptide (Ac-TNKKMRRNRFK-NH2, purchased 
from Insight Biotechnology) was determined by isothermal titration calorimetry (ITC) using a 
MicroCal™ iTC200 (GE Healthcare Life Sciences).  The protein and peptide samples were 
made up in the identical buffer (20 mM Hepes pH 8, 200 mM NaCl).  350 μl of protein sample 
(0.02 mM) and 200 μl of ligand (0.2 mM) were prepared for each experiment.  Sample 
concentrations were confirmed by amino acid analysis (PNAC Facility, Biochemistry 
Department, Cambridge University).  All experiments were conducted at 25°C.  The data was 
analysed using the Origin™ Software (MicroCal) using a one site binding model. 
 
Protein crystallography 
Diffraction quality crystals of the Importin-α1Δ
IBB
:HNF1β
NLS
 complex were obtained by sitting 
drop vapour diffusion where 200 nl of 10% PEG 8K, 0.09 M NPS, 20% ethylene glycol, 0.1 M 
Buffer 1 (Morpheus Screen, Molecular Dimensions) was mixed with 200 nl of Importin-
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9 
α1Δ
IBB
:HNF1β
NLS
.  The Importin-α1
ΔIBB
:HNF1β
NLS
 complex was produced by mixing Importin-
α1
ΔIBB
 and HNF1β
NLS
 peptide (Ac-TNKKMRRMRFK-NH2, Insight Biotechnology) at a 1:1.1 
molar ratio and a concentration of 6.7 mg/ml.  
 
 Crystals were cryoprotected in the mother liquor supplemented with 20% glycerol and 
cooled by plunging into liquid nitrogen.  X-ray diffraction data were collected on beamline I03 
at the Diamond Light Source (Didcot, UK).  Reflections were indexed and integrated using 
DIALS as implemented in Xia2 (Kabsch, 2010) and then scaled and merged in AIMLESS, 
ensuring a completeness of > 98% in the outermost shell while maintaining CC1/2 > 0.3 
(Evans and Murshudov, 2013).  The structure was solved by molecular replacement using 
Phaser with the structure of ΔIBB-mImportin-α1 complexed with a minor site small molecule 
inhibitor (PDB ID: 4U54 - Holvey et al., 2015) to avoid introducing model bias into the NLS 
binding sites.  Iterative cycles of rebuilding using COOT (Emsley et al., 2010) and refinement 
using PHENIX (Adams et al., 2010) were used to generate the final model (Table1) that had 
an R-factor of 18.4% (R-free = 22.0%) and a MolProbity score of 0.95 (100th percentile). 
 
Results and Discussion 
 
HNF1β is overexpressed in CCC cell lines 
HNF1β protein expression in different CCC cell lines was determined by Western blotting 
(Figure 1) using the HGSOC cell line PEO1 (which does not express HNF1β) as a negative 
control.  The CCC lines OVISE, JHOC5, JHOC7, JHOC9 and SKOV3 cell lines were used as 
models of CCC that overexpress HNF1β.  Several splice variants of HNF1β are known to 
contain different isoforms of the C-terminal domain that is responsible for activation of 
transcription.  These isoforms act as transdominant repressors (Bach and Yaniv, 1993).  Only 
the 61 kDa isoform of HNF1β was detected in our CCC cell lines (Figure 1) (Bach and Yaniv, 
1993; Tsuchiya et al., 2003).  HNF1β expression levels varied considerably between these 
cell lines.  Analysis of variance of the data in Figure 1 rejected the null hypothesis that the 
expression levels were equal (P < 0.002) and the higher level seen in JHOC7 compared with 
PEO1 cells was significant at the 0.5% level (using Sidak's modification for multiple 
comparisons), consistent with hypomethylation of the HNF1β CpG island (Kato et al., 2008; 
Kato et al., 2007). 
 
Identification of the HNF1β nuclear localisation signal 
To confirm the identity of the NLS, the PEO1 cell line was transduced with lentiviruses Lv103 
(eGFP-HNF1β), Lv105 (eGFP) and the 
229
KKMRRNR
235
 deletion mutant.  In cells transduced 
with eGFP-HNF1β, the fusion protein (eGFP-HNF1β (Lv103) - Figure 2A(Mutant 8)) was 
primarily nuclear, whereas cells transduced with Lv105 (eGFP) showed nuclear and 
cytoplasmic localisation of the eGFP protein (eGFP (Lv105) - Figure 2B).  Deletion of the 
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10 
seven-residue 
229
KKMRRNR
235
 NLS sequence in HNF1β resulted in its becoming 
mislocalized to the cytoplasm (Mutant 8, Figure 2C), confirming the importance of this 
sequence for the nuclear import of HNF1β. HNF1α has an analogous KKGRRN sequence 
that differs only at residue 231, where Met is changed to Gly (Wu et al., 2004) and which 
probably also functions in a similar manner.  Interestingly, all transduced cells (that were 
selected using optimised puromycin concentrations) were apoptotic within 24 h.  We 
speculate that re-expression of a transcription factor that is epigenetically silenced in HGSOC 
cell line PEO1 (Shen et al., 2013a) may have a negative effect on proliferation, but further 
work is necessary to determine the effects of re-expression. 
 
HNF1β
DBD
 binds primarily to the major site on Importin-α 
Because the sequence of the HNF1β NLS is similar to that of classical monopartite NLSs 
(Lange et al., 2007), HNF1β is likely to be imported by Importin-α and to interact with its major 
NLS-binding site rather than being imported by direct binding to Karyopherin-β (Fontes et al., 
2000).  To test whether HNF1β and mImportin-α formed a complex, recombinantly expressed 
and purified HNF1β
DBD
 and mImportin-α1 in which the IBB domain had been deleted (ΔIBB-
mImportin-α1) were mixed together and analysed by gel filtration chromatography (Figure 
3A), in which ΔIBB-mImportin-α1 and HNF1β
DBD
 co-eluted as a stoichiometric complex as 
observed by Coomassie blue stained SDS-PAGE analysis.  To establish whether HNF1β 
interacts with other Importin-α isoforms, pull-down experiments using different ΔIBB-
mImportin-α1 isoforms were performed (Figure 3B).  Crude extracts of GST-tagged HNF1β 
and ΔIBB-mImportin-α1 isoforms were mixed, then bound to glutathione resin, washed, and 
eluted by cleaving between GST and HNF1β
DBD
 using TEV protease.  Both HNF1β
DBD
 and 
ΔIBB-mImportin-α1 were released, confirming that they were interacting (Figure 3B).  HNF1β 
interacted more strongly with ΔIBB-mImportin-α5 and less strongly with ΔIBB-mImportin-α3, -
α4 and -α7 isoforms.  The Kd for the interaction of ΔIBB-mImportin-α1 with the HNF1β NLS 
peptide was determined by isothermal calorimetry (ITC) (Figure 4A) to be 13.6 ± 1.5 nM 
which was in the range commonly observed (Hodel et al., 2006).  In summary, HNF1β binds 
at least two ΔIBB-mImportin-α isoforms strongly and some other isoforms more weakly. 
 
 Three different Xenopus Importin-α1 (xImportin-α1) mutants (Giesecke and Stewart, 
2010) were used to define where the HNF1β NLS bound on Importin-α (Figure 4B).  These 
mutants contained point mutations that prevent binding via the major (D), minor (E), or both 
(ED) sites and also have the IBB domain removed to prevent auto-inhibition (Kobe, 1999).  
HNF1β
DBD
 bound to the E mutant but not the D or ED mutant of ΔIBB-xImportin-α1 (Figure 
4B), indicating that HNF1β binds primarily via the major site, consistent with its similarity to 
the SV40 NLS (Marfori et al., 2011). 
 
Structural characterisation of the interaction of mImportin-α1 with the HNF1β NLS 
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To complement the functional and biochemical data, we also determined the 2.4 Å resolution 
crystal structure of the HNF1β NLS peptide bound to ΔIBB-mImportin-α1 (Figure 5A).  After 
initial rounds of refinement, strong difference density, corresponding to the peptide was found 
in both the major NLS-binding site on Importin-α1 together with weaker density at the minor 
site (Figures 5B and C, respectively).  
 
 At the major site, the HNF1β NLS peptide backbone interacted with Importin-α1 via a 
set of conserved Asn residues on the import protein by H-bonding (Figure 6A).  The NLS 
residues are conventionally assigned to positions P1-P5 (Figure 6).  Key residues on 
Importin-α involved for the interaction with the NLS were Asn-235, 188 and 146, the latter two 
of which are involved in bidentate H-bonding with the NLS peptide backbone at P3 and P5.  
The aliphatic portions of the NLS peptide side chains were located in shallow pockets along 
the surface of Importin-α, but, as evident from Figure 6A, the P2 residue, Lys230, forms many 
critical interactions, mostly by forming salt bridges with negatively charged residues on 
Importin-α.  There were three interactions of the protonated nitrogen on the P2 lysine side 
chain with Asp192, Gly150 and Thr155.  Residue P5 interacted with the side-chain of Gln181. 
Furthermore, NLS residues P3 and P5 were stacked against the aromatic indole rings of 
Trp231, Trp184 and Trp142 on Importin-α, with the latter two being aligned in parallel.  
Interestingly, residues 
231
MRRNR
235
 also form part of the HNF1 DNA binding site identified 
by crystallography (Lu et al., 2007; PDB accession code 2H8R), which is analogous to the 
overlap between NLS and DNA binding seen in the androgen receptor (Cutress et al., 2008; 
PDB accession code 3BTR). 
 
 Weaker difference density was also observed in the minor NLS-binding site on 
Importin-α1 and displayed a partly α-helical conformation (Figure 6B).  Several atypical, minor 
site selective NLSs have previously been characterised structurally to adopt a similar 
topology (Chang et al., 2013; Nakada et al., 2015).  Our pull-down experiments with 
xImportin-α protein mutants have demonstrated that the interaction was primarily via the 
major site on Importin-α and so the presence of the peptide density in the minor site was 
probably due to the high protein concentration used to produce the crystals together with the 
peptide having additional degrees of freedom that may not present in the context of the intact 
HNF1β protein.  NLS residues Lys229 (P1), Met231 (P3) and Arg233 (P5) bound into apolar 
and shallow pockets consisting of aromatic tryptophan residues (Trp231, Trp184 and Trp142) 
stacked in parallel. 
 
 Identifying the HNF1 NLS and its mode of interaction with Importin- provides a 
basis of the design of therapeutic agents along the lines being investigated for other nuclear 
factors that aim to impair nuclear import to which cancer cells are often more sensitive 
(reviewed by Stelma et al. 2016).  For example, Lin et al. (1995) developed a 41-residue 
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synthetic peptide (that contained the NLS of transcription factor NF-κB together with a cSN50 
cell membrane permeable motif) that inhibited the nuclear translocation of NF-κB and 
attenuated gene transcription in intact cells, but was not cytotoxic within the concentration 
range of the experiments (Torgerson et al. 1998). 
 
 In summary, we have confirmed, using eGFP-tagged deletion constructs, that in the 
HNF1β transcription factor that is overexpressed in ovarian clear cell carcinoma, the 
sequence 
229
KKMRRNR
235
 is essential for its nuclear localisation in transduced cell lines.  
The HNF1β
DBD
 was identified to interact with a spectrum of Importin-α isoforms by pull-down 
assays and we have further characterised the interaction between the putative NLS peptide 
and Importin-α using complementary biophysical techniques.  Furthermore, we have 
determined the crystal structure of Importin-α in complex with the HNF1β NLS peptide to 
2.4 Å resolution.  This information should facilitate the development of compounds that target 
the nuclear import of the transcription factor.  We have shown that HNF1β interacts strongly 
with Importin-α5 and selectively targeting this Importin-HNF1β interaction may open new 
avenues for the development of targeted therapeutics for ovarian clear cell carcinoma along 
the lines discussed by Stelma et al. (2016). 
 
Data deposition 
Co-ordinates and structure factors for the structure of the HNF1 peptides bound to Importin-
 have been deposited at the Protein Data Bank (PDB) with accession code 5K9S. 
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Figure Legends 
 
Figure 1  (A) HNF1β protein expression levels in CCC cell lines OVISE, JHOC5, JHOC7, 
JHOC9, SKOV3 and a negative control HGSOC cell line, PEO1;  (B) Data is the mean (n = 3, 
three biological replicates) and SEM.  Expression levels were normalised to the 
housekeeping protein GAPDH.  The expression levels observed with JHOC5 (P < 0.005, ***) 
and OVISE (P < 0.05, *) cells were significantly higher than PEO1. 
 
Figure 2  eGFP imaging of PEO1 transduced lines with (a) eGFP-HNF1β (Lv103) showed 
primarily nuclear localisation of the GFP signal, whereas cells transduced with eGFP (Lv105) 
alone (b) showed both nuclear and cytoplasmic localisation.  In cells transduced with eGFP-
HNF1β (Lv103) in which the seven-residue NLS had been deleted (c, Mutant 8) the eGFP 
signal was mislocalized to the cytoplasm. The scale bar represents 80 μm. Images were 
taken on a Leica tandem confocal microscope using 20 x, 40 x and 60 x objectives. 
 
Figure 3 (A)  Stable complex formation between ΔIBB mouse Importin-α1 (50 kDa) and 
HNF1β (27 kDa) during size exclusion chromatography.   Fractions were analyzed by 
Coomassie stained SDS-PAGE (* marks the peak for the complex);  (B) GST pull-down with 
liberated HNF1β showing pull-downs using different ΔIBB mouse Importin-α isoforms (red *). 
 
Figure 4  (A) ITC titration for the binding of the HNF1β NLS peptide to ΔIBB mImportin-α1.  
Fitting the data (with 
2
/DoF = 2.9 X 10
4
) gave a Kd of 13.6 ± 1.5 nM for 0.94 ± 0.13 sites, H 
= -7.2 ± 1.6 kcal/mole, S = -1.7 cal/mol/deg. (B) In pull-down assays, GST-HNF1β bound 
only the E mutant of ΔIBB Xenopus Importin-α1 (that impairs NLS binding at the minor site) 
Mr 50 kD, but not the D mutant (that impairs binding at the major site) or ED double mutant 
(see Giesecke and Stewart, 2010). 
 
Figure 5 (A) Overview of the 2.4 Å crystal structure of the ΔIBB mouse Importin-α1:HNF1β
NLS
 
complex. Two copies of the NLS peptide were observed where one was bound in the major 
site (blue) and another in the minor site (yellow). Each ARM repeat of mouse Importin-α1 has 
been labelled with alternating colours. (B) Final 2Fo-Fc electron density map around NLS 
peptide in major and minor binding sites on mouse Importin-α1 contoured at 1σ. 
 
Figure 6 Schematic illustration of the interactions of the HNF1β
NLS
 peptide in the major (A) 
and minor (B) sites on ΔIBB mouse Importin-α1. 
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Abstract 
The transcription factor hepatocyte nuclear factor 1β (HNF1β) is ubiquitously overexpressed 
in ovarian clear cell carcinoma (CCC) and is a potential therapeutic target.  To explore 
potential approaches that block HNF1β transcription we have identified and characterised 
extensively the nuclear localisation signal (NLS) for HNF1β and its interactions with the 
nuclear protein import receptor, Importin-α.  Pull-down assays demonstrated that the DNA 
binding domain of HNF1β interacted with a spectrum of Importin-α isoforms and deletion 
constructs tagged with eGFP confirmed that the HNF1β 
229
KKMRRNR
235
 sequence was 
essential for nuclear localisation.  We further characterised the interaction between the NLS 
and Importin-α using complementary biophysical techniques and have determined the 2.4 Å 
resolution crystal structure of the HNF1β NLS peptide bound to Importin-α. The functional, 
biochemical, and structural characterisation of the nuclear localisation signal present on 
HNF1β and its interaction with the nuclear import protein Importin-α provide the basis for the 
development of compounds targeting transcription factor HNF1β via its nuclear import 
pathway. 
 
Keywords: Importin-α, nuclear import pathway, nuclear localisation signal sequence (NLS), 
Hepatocyte nuclear factor-1β (HNF1β), site-directed mutagenesis, X-ray crystallography, 
isothermal titration calorimetry. 
 
Abbreviations:  CCC - Ovarian clear cell carcinoma; HNF1 - hepatocyte nuclear factor 1;  
HNF1
DBD
 - HNF1 DNA binding domain; NLS - nuclear localization signal; IBB - Importin--
binding domain; mImportin-α - mouse Importin-α; xImportin-α - Xenopus Importin-α; GST - 
glutathione S-transferase. 
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Introduction 
Ovarian clear cell carcinoma (CCC) accounts for 5-10% of ovarian cancer cases (Anglesio et 
al., 2011; Kato et al., 2008).  Prognosis for patients with advanced stage or for relapsed 
disease is poor because of intrinsic resistance to platinum based chemotherapy and the lack 
of targeted therapies available (Tan et al., 2013; Tan and Kaye, 2007), although Bitler et al. 
(2015) have recently discovered a way of targeting cancers with ARID1A mutations by 
targeting EZH2 methyltransferase activity.  Common mutations in CCC include loss of 
function mutations in the chromatin remodeling gene ARID1A in 46–57% of cases (Jones et 
al., 2010; Wiegand et al., 2010), activating mutations in PIK3CA (Kuo et al., 2009) in 33–46% 
of cases, and loss of PTEN in 20% of cases (Anglesio et al., 2011; Landen et al., 2008; Tan 
and Kaye, 2007).  Overexpression of the HNF1β transcription factor is the most important 
clinical immunohistochemical marker for the disease because it is ubiquitously overexpressed 
in CCC, both at the mRNA and protein level (Hirotaka Kajihara, 2010; Kato et al., 2006; 
Tsuchiya et al., 2003; Yamaguchi et al., 2010).  In CCC the HNF1B gene is upregulated by 
hypomethylation of its CpG island whereas, in high grade serous ovarian cancer, HNF1β 
expression is silenced via hypermethylation (Kato et al., 2008; Shen et al., 2013a), 
suggesting that HNF1β has a loss of function (tumour suppressor) role in high grade serous 
ovarian cancer but a gain of function (oncogenic) role in CCC (Gounaris et al., 2011; Shen et 
al., 2013b).  This hypothesis is supported by the observation that nearly half of the 
overexpressed genes identified in CCC are downstream targets of HNF1β (Kobayashi et al., 
2009; Yoshida et al., 2009).  Evidence that targeting HNF1β might have utility was provided 
by Liu et al. (Liu et al., 2009) who showed that downregulation of HNF1β increased cisplatin- 
and paclitaxel-mediated cytotoxicity. 
 
 Transcription factor HNF1β (also known as vHNF1, vAPF, LF-B3 and Tcf2) is 
expressed in the liver, digestive tract, pancreas and the kidneys, where it plays a crucial role 
in early differentiation (Lu et al., 2007).  Sequence-specific DNA binding is mediated by a 
bipartite motif that consists of a POU homeodomain (POUH) and a POU specific domain 
(POUS) (Rosenfeld, 1991; Ryan and Rosenfeld, 1997).  HNF1β has 70% sequence homology 
to HNF1α and both proteins are atypical members of the POU transcription factor family and 
bind DNA as both homo- and heterodimers (Bach et al., 1991; Rey-Campos et al., 1991).  
Human HNF1β is constructed from three domains: the dimerization domain, which is further 
stabilised by the dimerization cofactor of HNF1 (DcoH), the transactivation domain, which is 
involved in binding transcriptional co-activators [15], and the POU DNA binding domain 
(HNF1
DBD
). 
 
 Transcription factors together with histones, DNA polymerase, RNA polymerase and 
many other proteins, have specific amino acid sequences, termed nuclear localisation signals 
(NLSs), that are recognised by members of the karyopherin family that facilitate their nuclear 
import (reviewed by Lange et al., 2007).  Many NLS sequences are recognised in the 
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cytoplasm by a heterodimeric transport carrier complex composed of Importin-β (also known 
as Karyopherin-β1) and Importin-α (reviewed by Stewart, 2007).  Nuclear pore complexes 
(NPCs) are the channels through which macromolecules, such as proteins and RNA, are 
transported between the cytoplasm and nucleus (reviewed by Stewart, 2007).  Small 
molecules and proteins (< 40 kDa) can pass through NPCs by passive diffusion, but larger 
proteins require carriers to overcome the NPC physical barrier.  The autoinhibitory Importin-
β binding (IBB) domain of Importin-α (Kobe, 1999) binds to Importin-β in the cytoplasm, 
enabling classical NLSs (cNLS) to bind to Importin-α either via a major site, a minor site, or 
both (Fontes et al., 2000; Lange et al., 2007). There are two types of cNLS that are 
recognised by Importin-α that consist of a either a single cluster (monopartite) or two clusters 
(bipartite) of positively charged residues, primarily lysines or arginines, that assume an 
ordered state once bound by Importin-α (reviewed by Lange et al. 2007; Marfori et al., 2011).  
Monopartite cNLSs are exemplified by the simian virus 40 large T-antigen (SV40) NLS 
126
PKKKRRV
132
 (Lange et al., 2007).  The cargo:carrier heterotrimer is then translocated into 
the nucleus in an energy dependent manner powered by RanGTPase (reviewed by Stewart, 
2007).  In the nucleus, RanGTP then binds Importin-β leading ultimately to the release of the 
cargo. 
 
 To function, HNF1β needs to be translocated to the cell nucleus and so we have 
investigated and characterized the putative NLS that has been proposed to lie between the 
two POU domains of HNF1β.  This putative NLS was identified in domain swapping 
experiments and studies of nephrogenesis, in which truncated GFP-HNF1β fusion constructs 
retaining the POUH domain showed exclusive nuclear localisation in transfected HeLa cells 
(Bohn et al., 2003; Wu et al., 2004).  However, the precise location of the HNF1β NLS has not 
been defined.  Because of the potential importance of HNF1β as a target in diseases such as 
CCC, we have identified and characterized extensively its NLS and its interactions with 
Importin-α.  We demonstrate that the sequence 
229
KKMRRNR
235
 in HNF1β
DBD
 is responsible 
for the nuclear import of the protein.  Several eGFP-constructs of HNF1β were generated and 
Importin-α binding of the HNF1β
DBD
 was assessed by both pull-down experiments and ITC.  
We also determined the crystal structure of the HNF1β NLS peptide bound to Importin-α.  The 
identification and structural characterisation of the HNF1β NLS and its interaction with the 
nuclear import protein Importin-α provides a basis for the development of inhibitors targeting 
the nuclear import of transcription factor HNF1β along the lines suggested by Stelma et al. 
(2016). 
 
Materials and Methods 
 
Mammalian cell culture 
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HEK293T cells were cultivated in Dulbecco’s Modified Eagle medium (DMEM) (1X) 
supplemented with 5% foetal bovine serum (FBS) (Invitrogen) and 0.5% 
penicillin/streptomycin (P/S).  CCC cell lines PEO1, JHOC5, JHOC7, JHOC9, OVISE and 
SKOV3 cells were grown in RPMI 1640 medium (1X) supplemented with 10% FBS and 
1% P/S.  Normal Ovarian Surface Epithelial (IOSE) cells were cultivated in NOSE-CM: MCDB 
105/medium 199 (1:1 ratio, Sigma Aldrich), 15% FBS, 10 ng/ml EGF (Invitrogen), 0.5 μg/ml 
hydrocortisone (Sigma Aldrich), 5 μg/ml insulin (Sigma Aldrich), 34 μg protein/ml BPE 
(Invitrogen).  All cell lines were maintained at 37°C in 5% CO2 and were mycoplasma tested 
on a regular basis (Biorepository Core, CRUK CI, Cambridge).  Cell counts were conducted 
using a Vi-CELL Cell Viability Analyzer. 
 
Protein extraction from mammalian cells 
Cell pellets were washed with phosphate buffered saline (PBS) and 200 μl protein lysis buffer 
(50 mM Tris pH 8.0, 150 mM NaCl, 5 mM EDTA, 0.5% Igepal, to which 2 tablets/100ml of 
protease inhibitor cocktail tablet (Roche)) was added.  The mixtures were incubated on ice for 
30 min, lysed by syringing four times using a 26 G needle, and centrifuged at 14,800 × g for 
10 min at 4°C.  Protein concentrations were measured using the DirectDetect IR 
spectrometer (Merck Millipore) according to the manufacturer’s instructions. 
 
Western blotting 
Denatured protein extracts were separated using NuPAGE Novex 4-20% Tris-Glycine gels 
and transferred to a Millipore Immobilon FL PVDF membrane (Invitrogen).  Primary 
antibodies were used as follows: goat anti-HNF1β (sc-7411, polyclonal, Santa Cruz 
Biotechnology, 1:1,000) and rabbit anti-GAPDH (G9545, 14C10, 1:5,000, Cell Signalling 
Technology).  An Odyssey Infrared Imaging System (Li-Cor) and associated secondary 
antibodies: donkey anti-goat (800) (1:15,000) and donkey anti-rabbit (800) (1:5,000) were 
used to detect material. The expression levels observed with different cells were evaluated 
using GraphPad Prism version 6.0 for Mac, GraphPad Software, La Jolla California USA, 
www.graphpad.com.  Analysis of variance rejected the null hypothesis that the expression 
levels were equal (P < 0.002) and Šídák's multiple comparison modification of Student's t-test 
was used to evaluate the significance of the levels seen with different cells relative to that 
seen with the control HGSOC cell line. 
 
Confocal microscopy: eGFP imaging and immunofluorescence assay 
For immunofluorescence (IF), cells were fixed with 4% paraformaldehyde in PBS for 10 min 
at room temperature, rinsed in Tris buffered saline (TBS) for 2 × 5 min and permealized in 
TBS-0.5% Triton X-100 for 10 min.  Fixed cells were then rinsed in TBS-0.1% Triton X-100 for 
3 × 3 min and blocked in 10% goat serum in TBS for 30 min.  HNF1β was stained with anti-
HNF1β (SAB1406512, mouse polyclonal, 1:300, Sigma Aldrich) overnight at 4°C. Cells were 
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washed with TBS-0.1% Triton X-100 (Fisher Scientific) for 3 × 5 min and the secondary 
antibody (AlexaFluor 568, goat anti-mouse IgG (H+L) 1:1,000, Invitrogen) was added and 
incubated for 60 min diluted in antibody dilution solution consisting of TBS - 0.1% Triton X-
100, 2% Bovine Serum Albumin (BSA) (Cell Signaling Technology) and 0.1% sodium azide.  
All experiments included an unstained control, a “secondary only” control, and a negative 
control using the PEO1 cell line.  Cells transduced with eGFP-HNF1β, the HNF1β 
229
KKMRRNR
235
 deletion mutant, or the control eGFP constructs, were fixed with 4% 
paraformaldehyde in PBS for 10 min at room temperature, then rinsed in TBS for 2 × 5 min.  
Nuclei were stained using DAPI (1 μg/ml in TBS) for 10 min.  Cells were washed in TBS-0.1% 
Triton X-100, rinsed in TBS and stored in TBS-0.1% Triton X-100.  For microscopy imaging, 
cover slips were drained, mounted and sealed using Prolong Gold (Invitrogen) and glass 
slides (Thermo Specific).  Slides were left to dry overnight at room temperature in the 
absence of light and were then stored at 4◦C.  Cells were imaged using a Leica tandem 
confocal microscope. 
 
Site directed mutagenesis to generate HNF1β NLS deletion construct 
Lv103 (EX-F0366-Lv103, Genecopoeia) is a lentiviral transfer vector containing an eGFP-
HNF1β fusion coding sequence.  Lv105 (EX-EGFP-Lv105, Genecopoeia) only contains the 
eGFP coding sequence.  The plasmids were confirmed by sequencing (GATC, Konstanz, 
Germany) before and after mutagenesis (Lv103 Fw: 5’-CCGACAACCACTACCTGA-3’; Rv: 5’-
ATTGTGGATGAATACTGCC-3’ and Lv105 Fw: 5’-ATCCACGCTGTTTTGACC-3’; Rv: 5’-
AATACTGCCATTTGTCTCG-3’). 
 
 Mutagenesis experiments were conducted using the Q5 site directed mutagenesis kit 
(NEB).  The 
229
KKMRRNR
235
 deletion construct was generated using mutagenesis primers 
(Fw: 5’-TTCAAATGGGGGCCGC-3’; Rv: 5’-GTTGGTGGGCTCAGAGCAG-3’).  Plasmids 
were then transformed in E. coli (One Shot® Stbl3™, Invitrogen) and streaked on Amp-
containing agar plates.  Single colonies were picked and tested for plasmid containing 
colonies by PCR.  Plasmids were extracted by Plasmid Mini Prep (Qiagen) and quantified 
(Qubit). 
 
Lentivirus production and transduction 
The general protocol devised by Cribbs et al. (2013) was used for lentivirus production. The 
transfer vectors Lv103, Lv105, the 
229
KKMRRNR
235
 deletion mutant, and plasmids pRVS-Rev, 
pVSV-G, and p-MDLg-pRRE were verified by restriction digest.  For each transfection 
sample, 16 μg transfer vector, 10.4 μg pMDL/pRRE, 4 μg pRSV-Rev and 5.6 μg pVSV-G 
were used.  After 24 h, expression of GFP protein was observed in the GFP control virus 
HEK293T sample.  Virus containing supernatant was harvested posttransfection according to 
the protocol by Kutner et al. (2009). The number of transducing units (TU) was determined by 
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flow cytometry analysis with GFP as the reporter protein.  For titration, 1 × 10
5
 cells per well 
were seeded in a 12-well plate and 0.5 ml DMEM with 5% FBS added.  Virus of respective 
concentration was pipetted over the HEK293T cells.  Duplicate virus dilutions of 1:500, 
1:1000, 1:2000, 1:5000 were added.  An untreated control was included.  The medium was 
changed 24 h posttransfection.  72 h posttransfection cells were harvested by trypsinization.  
Cells were collected by centrifugation at 500 × g for 5 min at room temperature.  The 
supernatant was discarded and cell pellets were resuspended in PBS.  A green fluorescent 
protein propidium iodide (GFP PI) based assay for flow cytometric measurement of 
transfection efficiency and cell viability was performed (LSR-II machine).  The titre was 
calculated from dilutions that gave 1–40% GFP-positivity and averaged subsequently using 
the following formula: 
 
       
  
  
  
                                                                      
                  
 
 
where, frequency of GFP-positive cells is the percentage of cells that are positive for GFP 
divided by 100 (acceptable range: 0.01–0.40), dilution factor is the dilution of the virus stock 
used and volume of inoculum is the total volume transduced.  The titre was calculated to be 
         
  
  
. 
 
 For transduction of the PEO1 cell line,         cells per well were seeded in a 12-
well plate to which 0.5 ml of the respective medium was added.  Virus was added so that the 
desired multiplicity of infection (MOI) was obtained.  Polybrene 0.5-10 μg/ml was added to 
increase transduction efficiency.  Transduction efficiencies were determined by flow 
cytometry analysis using an LSR-II machine.  For selection of transduced PEO1 lines, a 
puromycin kill curve was constructed (data not shown) to determine the optimum 
concentration of puromycin required to kill all untransduced cells while minimising toxicity 
effects in transduced cells.  A puromycin concentration of 0.1 μg/ml was determined which 
was used in all experiments. 
 
Quick change mutagenesis to generate GST-tagged HNF1β
DBD
 and mImportin α1 
mutants 
The cloning of the DNA binding domain of HNF1β into the pGEX-TEV plasmid was conducted 
as described by Lu et al. (2006).  The plasmid was confirmed by sequencing by Source 
Bioscience (Cambridge, UK) using PGEX5 and PGEX3 primers (Source Bioscience). 
 
Protein expression in bacterial cells and purification 
All proteins were expressed in E. coli BL21 (DE3) CodonPlus-RIL cells using IPTG induction 
over 18 h at 18°C. The cells were harvested by centrifugation and resuspended in 50 mM 
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Tris/HCl pH 8.0, 500 mM NaCl, 5 mM DTT for GST-tagged constructs or 50 mM Tris/HCl pH 
8.0, 500 mM NaCl, 20 mM Imidazole pH 8.0 for His6-tagged proteins.  The E. coli were lysed 
by two passes through an Emulsiflex C3 system (AVESTIN) running at a pressure of 
15,000 psi and the lysates clarified by centrifugation at 48,000 × g.  Either Ni-NTA agarose 
resin (QIAGEN) or glutathione Sepharose 4B resin (GE Healthcare) was added to the 
clarified lysate containing His6-tagged proteins or GST-tagged proteins.  The resin was 
pooled and packed into a gravity filtration column and washed extensively with their 
respective lysis buffers.  1 mg of TEV protease (purified in-house) was added to the washed 
resin and incubated for 18 h at 4°C.  The tag-free protein of interest was then collected from 
the flow-through and subjected to the next purification step.  HNF1β
DBD
 was purified further by 
heparin affinity chromatography using a HiTrap Heparin HP column (GE Healthcare Life 
Sciences).  HNF1β
DBD
 was eluted from the column using a 0.1 - 1 M NaCl gradient.  All 
proteins were purified to homogeneity by size exclusion chromatography using a HiLoad™ 
26/60 Superdex™ 75 prep grade column (GE Healthcare) pre-equilibrated in 20 mM HEPES 
buffer pH 8.0, 200 mM NaCl.  Fractions containing pure and homogenous proteins identified 
by SDS-PAGE analysis were pooled and concentrated using an Amicon Ultra 15 
centrifugation filtration unit.  Protein concentrations were measured using a Nanodrop 
(Thermo) microspectrophotometer and small aliquots of the protein were flash frozen in liquid 
nitrogen and stored at -80°C until required. 
 
GST pull-downs 
After bacterial cell lysis, cell pellets expressing the two proteins of interest were mixed and 
pull-down experiments were conducted as described above for glutathione affinity 
chromatography and were visualised by SDS-page analysis. 
 
Isothermal calorimetry 
The Kd of mImportin-α1 with the HNF1β NLS peptide (Ac-TNKKMRRNRFK-NH2, purchased 
from Insight Biotechnology) was determined by isothermal titration calorimetry (ITC) using a 
MicroCal™ iTC200 (GE Healthcare Life Sciences).  The protein and peptide samples were 
made up in the identical buffer (20 mM Hepes pH 8, 200 mM NaCl).  350 μl of protein sample 
(0.02 mM) and 200 μl of ligand (0.2 mM) were prepared for each experiment.  Sample 
concentrations were confirmed by amino acid analysis (PNAC Facility, Biochemistry 
Department, Cambridge University).  All experiments were conducted at 25°C.  The data was 
analysed using the Origin™ Software (MicroCal) using a one site binding model. 
 
Protein crystallography 
Diffraction quality crystals of the Importin-α1Δ
IBB
:HNF1β
NLS
 complex were obtained by sitting 
drop vapour diffusion where 200 nl of 10% PEG 8K, 0.09 M NPS, 20% ethylene glycol, 0.1 M 
Buffer 1 (Morpheus Screen, Molecular Dimensions) was mixed with 200 nl of Importin-
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α1Δ
IBB
:HNF1β
NLS
.  The Importin-α1
ΔIBB
:HNF1β
NLS
 complex was produced by mixing Importin-
α1
ΔIBB
 and HNF1β
NLS
 peptide (Ac-TNKKMRRMRFK-NH2, Insight Biotechnology) at a 1:1.1 
molar ratio and a concentration of 6.7 mg/ml.  
 
 Crystals were cryoprotected in the mother liquor supplemented with 20% glycerol and 
cooled by plunging into liquid nitrogen.  X-ray diffraction data were collected on beamline I03 
at the Diamond Light Source (Didcot, UK).  Reflections were indexed and integrated using 
DIALS as implemented in Xia2 (Kabsch, 2010) and then scaled and merged in AIMLESS, 
ensuring a completeness of > 98% in the outermost shell while maintaining CC1/2 > 0.3 
(Evans and Murshudov, 2013).  The structure was solved by molecular replacement using 
Phaser with the structure of ΔIBB-mImportin-α1 complexed with a minor site small molecule 
inhibitor (PDB ID: 4U54 - Holvey et al., 2015) to avoid introducing model bias into the NLS 
binding sites.  Iterative cycles of rebuilding using COOT (Emsley et al., 2010) and refinement 
using PHENIX (Adams et al., 2010) were used to generate the final model (Table1) that had 
an R-factor of 18.4% (R-free = 22.0%) and a MolProbity score of 0.95 (100th percentile). 
 
Results and Discussion 
 
HNF1β is overexpressed in CCC cell lines 
HNF1β protein expression in different CCC cell lines was determined by Western blotting 
(Figure 1) using the HGSOC cell line PEO1 (which does not express HNF1β) as a negative 
control.  The CCC lines OVISE, JHOC5, JHOC7, JHOC9 and SKOV3 cell lines were used as 
models of CCC that overexpress HNF1β.  Several splice variants of HNF1β are known to 
contain different isoforms of the C-terminal domain that is responsible for activation of 
transcription.  These isoforms act as transdominant repressors (Bach and Yaniv, 1993).  Only 
the 61 kDa isoform of HNF1β was detected in our CCC cell lines (Figure 1) (Bach and Yaniv, 
1993; Tsuchiya et al., 2003).  HNF1β expression levels varied considerably between these 
cell lines.  Analysis of variance of the data in Figure 1 rejected the null hypothesis that the 
expression levels were equal (P < 0.002) and the higher level seen in JHOC7 compared with 
PEO1 cells was significant at the 0.5% level (using Sidak's modification for multiple 
comparisons), consistent with hypomethylation of the HNF1β CpG island (Kato et al., 2008; 
Kato et al., 2007). 
 
Identification of the HNF1β nuclear localisation signal 
To confirm the identity of the NLS, the PEO1 cell line was transduced with lentiviruses Lv103 
(eGFP-HNF1β), Lv105 (eGFP) and the 
229
KKMRRNR
235
 deletion mutant.  In cells transduced 
with eGFP-HNF1β, the fusion protein (eGFP-HNF1β (Lv103) - Figure 2A(Mutant 8)) was 
primarily nuclear, whereas cells transduced with Lv105 (eGFP) showed nuclear and 
cytoplasmic localisation of the eGFP protein (eGFP (Lv105) - Figure 2B).  Deletion of the 
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seven-residue 
229
KKMRRNR
235
 NLS sequence in HNF1β resulted in its becoming 
mislocalized to the cytoplasm (Mutant 8, Figure 2C), confirming the importance of this 
sequence for the nuclear import of HNF1β. HNF1α has an analogous KKGRRN sequence 
that differs only at residue 231, where Met is changed to Gly (Wu et al., 2004) and which 
probably also functions in a similar manner.  Interestingly, all transduced cells (that were 
selected using optimised puromycin concentrations) were apoptotic within 24 h.  We 
speculate that re-expression of a transcription factor that is epigenetically silenced in HGSOC 
cell line PEO1 (Shen et al., 2013a) may have a negative effect on proliferation, but further 
work is necessary to determine the effects of re-expression. 
 
HNF1β
DBD
 binds primarily to the major site on Importin-α 
Because the sequence of the HNF1β NLS is similar to that of classical monopartite NLSs 
(Lange et al., 2007), HNF1β is likely to be imported by Importin-α and to interact with its major 
NLS-binding site rather than being imported by direct binding to Karyopherin-β (Fontes et al., 
2000).  To test whether HNF1β and mImportin-α formed a complex, recombinantly expressed 
and purified HNF1β
DBD
 and mImportin-α1 in which the IBB domain had been deleted (ΔIBB-
mImportin-α1) were mixed together and analysed by gel filtration chromatography (Figure 
3A), in which ΔIBB-mImportin-α1 and HNF1β
DBD
 co-eluted as a stoichiometric complex as 
observed by Coomassie blue stained SDS-PAGE analysis.  To establish whether HNF1β 
interacts with other Importin-α isoforms, pull-down experiments using different ΔIBB-
mImportin-α1 isoforms were performed (Figure 3B).  Crude extracts of GST-tagged HNF1β 
and ΔIBB-mImportin-α1 isoforms were mixed, then bound to glutathione resin, washed, and 
eluted by cleaving between GST and HNF1β
DBD
 using TEV protease.  Both HNF1β
DBD
 and 
ΔIBB-mImportin-α1 were released, confirming that they were interacting (Figure 3B).  HNF1β 
interacted more strongly with ΔIBB-mImportin-α5 and less strongly with ΔIBB-mImportin-α3, -
α4 and -α7 isoforms.  The Kd for the interaction of ΔIBB-mImportin-α1 with the HNF1β NLS 
peptide was determined by isothermal calorimetry (ITC) (Figure 4A) to be 13.6 ± 1.54E-3 μM 
which was in the range commonly observed (Hodel et al., 2006).  In summary, HNF1β binds 
at least two ΔIBB-mImportin-α isoforms strongly and some other isoforms more weakly. 
 
 Three different Xenopus Importin-α1 (xImportin-α1) mutants (Giesecke and Stewart, 
2010) were used to define where the HNF1β NLS bound on Importin-α (Figure 4B).  These 
mutants contained point mutations that prevent binding via the major (D), minor (E), or both 
(ED) sites and also have the IBB domain removed to prevent auto-inhibition (Kobe, 1999).  
HNF1β
DBD
 bound to the E mutant but not the D or ED mutant of ΔIBB-xImportin-α1 (Figure 
4B), indicating that HNF1β binds primarily via the major site, consistent with its similarity to 
the SV40 NLS (Marfori et al., 2011). 
 
Structural characterisation of the interaction of mImportin-α1 with the HNF1β NLS 
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To complement the functional and biochemical data, we also determined the 2.4 Å resolution 
crystal structure of the HNF1β NLS peptide bound to ΔIBB-mImportin-α1 (Figure 5A).  After 
initial rounds of refinement, strong difference density, corresponding to the peptide was found 
in both the major NLS-binding site on Importin-α1 together with weaker density at the minor 
site (Figures 5B and C, respectively).  
 
 At the major site, the HNF1β NLS peptide backbone interacted with Importin-α1 via a 
set of conserved Asn residues on the import protein by H-bonding (Figure 6A).  The NLS 
residues are conventionally assigned to positions P1-P5 (Figure 6).  Key residues on 
Importin-α involved for the interaction with the NLS were Asn-235, 188 and 146, the latter two 
of which are involved in bidentate H-bonding with the NLS peptide backbone at P3 and P5.  
The aliphatic portions of the NLS peptide side chains were located in shallow pockets along 
the surface of Importin-α, but, as evident from Figure 6A, the P2 residue, Lys230, forms many 
critical interactions, mostly by forming salt bridges with negatively charged residues on 
Importin-α.  There were three interactions of the protonated nitrogen on the P2 lysine side 
chain with Asp192, Gly150 and Thr155.  Residue P5 interacted with the side-chain of Gln181. 
Furthermore, NLS residues P3 and P5 were stacked against the aromatic indole rings of 
Trp231, Trp184 and Trp142 on Importin-α, with the latter two being aligned in parallel.  
Interestingly, residues 
231
MRRNR
235
 also form part of the HNF1 DNA binding site identified 
by crystallography (Lu et al., 2007; PDB accession code 2H8R), which is analogous to the 
overlap between NLS and DNA binding seen in the androgen receptor (Cutress et al., 2008; 
PDB accession code 3BTR). 
 
 Weaker difference density was also observed in the minor NLS-binding site on 
Importin-α1 and displayed a partly α-helical conformation (Figure 6B).  Several atypical, minor 
site selective NLSs have previously been characterised structurally to adopt a similar 
topology (Chang et al., 2013; Nakada et al., 2015).  Our pull-down experiments with 
xImportin-α protein mutants have demonstrated that the interaction was primarily via the 
major site on Importin-α and so the presence of the peptide density in the minor site was 
probably due to the high protein concentration used to produce the crystals together with the 
peptide having additional degrees of freedom that may not present in the context of the intact 
HNF1β protein.  NLS residues Lys229 (P1), Met231 (P3) and Arg233 (P5) bound into apolar 
and shallow pockets consisting of aromatic tryptophan residues (Trp231, Trp184 and Trp142) 
stacked in parallel. 
 
 Identifying the HNF1 NLS and its mode of interaction with Importin- provides a 
basis of the design of therapeutic agents along the lines being investigated for other nuclear 
factors that aim to impair nuclear import to which cancer cells are often more sensitive 
(reviewed by Stelma et al. 2016).  For example, Lin et al. (1995) developed a 41-residue 
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synthetic peptide (that contained the NLS of transcription factor NF-κB together with a cSN50 
cell membrane permeable motif) that inhibited the nuclear translocation of NF-κB and 
attenuated gene transcription in intact cells, but was not cytotoxic within the concentration 
range of the experiments (Torgerson et al. 1998). 
 
 In summary, we have confirmed, using eGFP-tagged deletion constructs, that in the 
HNF1β transcription factor that is overexpressed in ovarian clear cell carcinoma, the 
sequence 
229
KKMRRNR
235
 is essential for its nuclear localisation in transduced cell lines.  
The HNF1β
DBD
 was identified to interact with a spectrum of Importin-α isoforms by pull-down 
assays and we have further characterised the interaction between the putative NLS peptide 
and Importin-α using complementary biophysical techniques.  Furthermore, we have 
determined the crystal structure of Importin-α in complex with the HNF1β NLS peptide to 
2.4 Å resolution.  This information should facilitate the development of compounds that target 
the nuclear import of the transcription factor.  We have shown that HNF1β interacts strongly 
with Importin-α5 and selectively targeting this Importin-HNF1β interaction may open new 
avenues for the development of targeted therapeutics for ovarian clear cell carcinoma along 
the lines discussed by Stelma et al. (2016). 
 
Data deposition 
Co-ordinates and structure factors for the structure of the HNF1 peptides bound to Importin-
 have been deposited at the Protein Data Bank (PDB) with accession code 5K9S. 
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Figure Legends 
 
Figure 1  (A) HNF1β protein expression levels in CCC cell lines OVISE, JHOC5, JHOC7, 
JHOC9, SKOV3 and a negative control HGSOC cell line, PEO1;  (B) Data is the mean (n = 3, 
three biological replicates) and SEM.  Expression levels were normalised to the 
housekeeping protein GAPDH.  The expression levels observed with JHOC5 (P < 0.005, ***) 
and OVISE (P < 0.05, *) cells were significantly higher than PEO1. 
 
Figure 2  eGFP imaging of PEO1 transduced lines with (a) eGFP-HNF1β (Lv103) showed 
primarily nuclear localisation of the GFP signal, whereas cells transduced with eGFP (Lv105) 
alone (b) showed both nuclear and cytoplasmic localisation.  In cells transduced with eGFP-
HNF1β (Lv103) in which the seven-residue NLS had been deleted (c, Mutant 8) the eGFP 
signal was mislocalized to the cytoplasm. The scale bar represents 80 μm. Images were 
taken on a Leica tandem confocal microscope using 20 x, 40 x and 60 x objectives. 
 
Figure 3 (A)  Stable complex formation between ΔIBB mouse Importin-α1 (50 kDa) and 
HNF1β (27 kDa) during size exclusion chromatography.   Fractions were analyzed by 
Coomassie stained SDS-PAGE (* marks the peak for the complex);  (B) GST pull-down with 
liberated HNF1β showing pull-downs using different ΔIBB mouse Importin-α isoforms (red *). 
 
Figure 4  (A) ITC titration for the binding of the HNF1β NLS peptide to ΔIBB mImportin-α1.  
Fitting the data (with 
2
/DoF = 2.9 X 10
4
) gave a Kd of 13.6 ± 1.5 nM for 0.94 ± 0.13 sites, H 
= -7.2 ± 1.6 kcal/mole, S = -1.7 cal/mol/deg. (B) In pull-down assays, GST-HNF1β bound 
only the E mutant of ΔIBB Xenopus Importin-α1 (that impairs NLS binding at the minor site) 
Mr 50 kD, but not the D mutant (that impairs binding at the major site) or ED double mutant 
(see Giesecke and Stewart, 2010). 
 
Figure 5 (A) Overview of the 2.4 Å crystal structure of the ΔIBB mouse Importin-α1:HNF1β
NLS
 
complex. Two copies of the NLS peptide were observed where one was bound in the major 
site (blue) and another in the minor site (yellow). Each ARM repeat of mouse Importin-α1 has 
been labelled with alternating colours. (B) Final 2Fo-Fc electron density map around NLS 
peptide in major and minor binding sites on mouse Importin-α1 contoured at 1σ. 
 
Figure 6 Schematic illustration of the interactions of the HNF1β
NLS
 peptide in the major (A) 
and minor (B) sites on ΔIBB mouse Importin-α1. 
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Table 1 - Protein Crystallography Parameters for ΔIBB-mImportin-α1 complexed with 
the HNF1β NLS peptide 
 
Data collection statistics  
Wavelength (Å) 0.97624 
Space group C2221 
Unit cell parameters: a, b, c (Å); α, β, γ (°) 81.4, 111.4, 129.4; 90.0, 90.0, 90.0 
Resolution range (outer shell in brackets; Å) 129.4 - 2.40 (2.49 - 2.40) 
Unique reflections 23388 (2414) 
Total observations 173271 (18283) 
<I / σ(I)>: all (outer shell) 10.2 (1.8) 
Rp.i.m.: all (outer shell) 0.041 (0.60) 
Completeness: all (outer shell) (%) 100 (100) 
Multiplicity  7.4 
Wilson B-factor 53.7 
Refinement statistics   
Non-hydrogen atoms 3500 
Number of water molecules 53 
Bond length deviation from ideal values (Å) 0.008 
Bond angle deviation from ideal values (°) 0.78 
Ramachandran favoured/outliers (%) 98.9 / 0 
All-atom clashscore 1.86 
Average protein B factor 67.2 
Average water B factor 61.4 
Rwork/Rfree (%) 
MolProbity score (percentile) 
18.4 / 22.0 
0.95 (100) 
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